Submucosal glands of airway |
Myoepithelial cell |
Naphthalene, sulfur dioxide, influenza injury |
Myoepithelial, transitional basal cell to secretory and multiciliated cells |
Conducting airway |
Basal Cells |
Homeostasis |
Basal, secretory, tuft, neuroendocrine, and ionocytes |
Sulfur dioxide, naphthalene |
Basal, secretory, multiciliated cells |
Influenza |
SOX2+/KRT5+/TRP63+ basal transition cell into AT2s upon inhibition of NOTCH, prevention of hypoxia-induced events, and WNT activation |
Secretory Cells |
Homeostasis |
Secretory, multiciliated cells |
Basal cell depletion, sulfur dioxide, influenza |
Dedifferentiated basal, secretory, multiciliated cells |
Naphthalene, sulfur dioxide |
Basal, secretory, tuft, neuroendocrine, and ionocytes |
Variant Secretory (NEB niche) |
Homeostasis or naphthalene injury |
Secretory, multiciliated cells |
Bleomycin |
AT2s, AT1s |
Bronchioalveolar stem cells |
Homeostasis |
Secretory and AT2, (rare AT1) |
Naphthalene |
Secretory, multiciliated cells |
Bleomycin |
AT2, AT1 |
Influenza |
Secretory, AT2 |
Alveolar |
Type 1 |
Homeostasis, |
AT1 |
Pneumonectomy |
AT1, AT2 |
Type 2 |
Homeostasis, bleomycin, AT2 depletion model, pneumonectomy |
AT2, AT1 |
AEP |
Homeostasis |
AT2 (rare AT1) |
Influenza, lung epithelial deletion model |
AT2, AT1 |
a4b6/SFTPC- |
Bleomycin |
AT2s |